Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer

• المؤلفون الرئيسيون: Chaiyut Charoentum, Sumitra Thongprasert, Busayamas Chewasakulyong, Juntima Euathrongchit, Sirikul Sorraritchingchai, Sutthirak Munprakan
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=37149053450&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/61239

Objective: To assess the activity and toxicity of cisplatin and irinotecan alternating with docetaxel in patients with advanced non-small cell lung cancer (NSCLC). Material and Method: Eligibility included chemo-naïve stage IIIB with malignant effusion and stage IV NSCLC patients with measurable dis...